Welcome to our dedicated page for Leonardo DRS SEC filings (Ticker: DRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Leonardo DRS, Inc. (Nasdaq: DRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Leonardo DRS is a defense technology company headquartered in Arlington, Virginia, with common stock registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC under the symbol DRS.
Through this page, users can review Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s two primary segments, Advanced Sensing and Computing and Integrated Mission Systems, along with risk factors, contract information and financial results. Form 8-K current reports document material events such as leadership transitions, board changes, earnings releases and other significant corporate developments, including updates to executive employment agreements and conference call announcements.
Investors interested in ownership and governance details can also look for proxy statements and related filings that discuss board composition and committee responsibilities. In addition, Form 4 insider transaction reports, when available, show purchases and sales of DRS common stock by directors, officers and other insiders.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major contracts in areas like advanced sensing, network computing, force protection, and electric power and propulsion, and notable changes in leadership or governance. Real-time updates from EDGAR ensure that new Leonardo DRS filings, including earnings-related 8-Ks and other disclosures, are added as they become available, giving users a structured view of the company’s regulatory history and ongoing reporting obligations.
Leonardo DRS, Inc. entered into a new five-year senior unsecured $500 million revolving credit facility with a syndicate of lenders led by JPMorgan Chase Bank. The facility can be drawn over time for working capital and other general corporate purposes, and can be prepaid at any time without penalty.
U.S. subsidiaries guarantee the obligations, and the agreement includes financial covenants such as a maximum total net leverage ratio of 3.75 to 1.00, with a temporary step-up to 4.00 to 1.00 for certain acquisitions, and a minimum net interest coverage ratio of 3.00 to 1.00. At the same time, the company terminated its prior 2022 credit agreement, which had no outstanding borrowings and carried no early termination penalties.
Leonardo DRS, Inc. executive Jason Rinsky, EVP Chief Tax and Treasury, reported his equity holdings in a Form 3 insider filing. He directly owns 12,315 shares of common stock and three blocks of restricted stock units covering 8,367, 7,590, and 5,375 shares of common stock.
These RSUs were granted under the company’s 2022 Omnibus Equity Compensation Plan and each unit represents the right to receive one share of common stock or its cash equivalent. The awards vest in stages between April 1, 2026 and April 1, 2028, conditioned on continued employment.
Leonardo DRS EVP and Chief Operating Officer Sally Wallace reported selling 1,300 shares of Leonardo DRS, Inc. common stock at $35.17 per share on January 5, 2026. After this sale, she reports beneficial ownership of 58,353 shares held directly. The transaction was executed under a pre-established Rule 10b5-1 trading plan that she adopted on August 6, 2025.
Leonardo DRS, Inc. executive Mark Dorfman, EVP, GC and Secretary, reported a planned stock sale. On 01/05/2026 he sold 7,680 shares of Leonardo DRS common stock at a price of $37 per share, leaving him with 27,680 shares beneficially owned after the transaction.
The filing notes that these sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025, indicating the trades were scheduled in advance rather than made on an ad hoc basis.
Leonardo DRS, Inc. executive vice president and chief financial officer Michael Dippold reported selling 10,588 shares of common stock on January 5, 2026 at $37 per share. After this transaction, he directly held 42,952 shares of Leonardo DRS common stock. The filing notes that these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Leonardo DRS, Inc. filed an Amendment No. 1 to its quarterly report for the period ended September 30, 2025 to add information that was inadvertently omitted about an executive stock trading plan. The amendment updates the section on securities trading plans to disclose that Executive Vice President Operations Sally A. Wallace adopted a Rule 10b5-1 trading arrangement on August 6, 2025 covering up to 38,987 shares of common stock, with a scheduled expiration date of October 30, 2026. As of October 28, 2025, the company had 266,026,725 shares of common stock outstanding. The company states that no financial statements or other disclosures from the original quarterly report are being changed by this amendment.
Leonardo DRS received a notice under Rule 144 for a planned sale of restricted stock. An affiliated holder plans to sell 1,300 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $45,721.00.
The shares were acquired on 11/29/2024 through restricted stock vesting as compensation from the issuer. The notice lists 266,026,725 common shares outstanding for the issuer and indicates an approximate sale date of 01/05/2026.
Leonardo DRS (DRS) reported an insider transaction by a director. On 11/13/2025, the reporting person disposed of 2,600 shares of common stock as a gift (transaction code G) at $0 per share. Following this transaction, the reporting person beneficially owns 27,720 shares, held directly. The filing was made by one reporting person.
Leonardo DRS (DRS) reported strong Q3 2025 results. Revenue reached $960 million, up 18% year over year, with diluted EPS of $0.26 and net earnings of $72 million. Operating earnings were $93 million as gross margin improved to 23.1% from 22.0%.
Year to date, revenue was $2.588 billion (up 15%) and diluted EPS was $0.65. Backlog totaled $8.909 billion as of September 30, 2025, and Q3 bookings were $1.307 billion. Segment revenue was $580 million for Advanced Sensing & Computing and $383 million for Integrated Mission Systems.
Cash and equivalents were $309 million, with total debt of $350 million and no borrowings on the $275 million revolver. Net cash used in operating activities was $59 million for the first nine months. The company repurchased $24 million of stock under a $75 million program and paid $0.27 per share in dividends year to date; a $0.09 per share dividend was declared for payment on December 2, 2025. Subsequent to quarter end, John Baylouny was appointed President & CEO effective January 1, 2026; Frances F. Townsend will become Board Chair the same day.
Leonardo DRS (DRS) reported strong Q3 2025 results. Revenue reached $960 million, up 18% year over year, with diluted EPS of $0.26 and net earnings of $72 million. Operating earnings were $93 million as gross margin improved to 23.1% from 22.0%.
Year to date, revenue was $2.588 billion (up 15%) and diluted EPS was $0.65. Backlog totaled $8.909 billion as of September 30, 2025, and Q3 bookings were $1.307 billion. Segment revenue was $580 million for Advanced Sensing & Computing and $383 million for Integrated Mission Systems.
Cash and equivalents were $309 million, with total debt of $350 million and no borrowings on the $275 million revolver. Net cash used in operating activities was $59 million for the first nine months. The company repurchased $24 million of stock under a $75 million program and paid $0.27 per share in dividends year to date; a $0.09 per share dividend was declared for payment on December 2, 2025. Subsequent to quarter end, John Baylouny was appointed President & CEO effective January 1, 2026; Frances F. Townsend will become Board Chair the same day.
Leonardo DRS (DRS) announced a planned CEO transition. William J. Lynn III will retire as Chief Executive Officer, Non-Proxy Holder Director, and Chairman effective at midnight on December 31, 2025, and remain an employee through April 1, 2026. The Board appointed John Baylouny as President and Chief Executive Officer, and as a Non-Proxy Holder Director, effective January 1, 2026.
The company entered into an employment agreement with Mr. Baylouny providing a 2026 base salary of $950,000, a target annual incentive equal to 120% of base salary (maximum 200% of target), and a 2026 long‑term incentive target of $2,500,000 under the 2022 Omnibus Equity Compensation Plan. If terminated by the company other than for cause, he is eligible for a lump sum equal to two times base salary, specified bonus components, continued vesting treatment on equity awards, and up to 18 months of COBRA and welfare benefits.
The Board also appointed Frances F. Townsend as Chair effective January 1, 2026. A news release covering these changes was furnished under Item 7.01.
Leonardo DRS (DRS) announced a planned CEO transition. William J. Lynn III will retire as Chief Executive Officer, Non-Proxy Holder Director, and Chairman effective at midnight on December 31, 2025, and remain an employee through April 1, 2026. The Board appointed John Baylouny as President and Chief Executive Officer, and as a Non-Proxy Holder Director, effective January 1, 2026.
The company entered into an employment agreement with Mr. Baylouny providing a 2026 base salary of $950,000, a target annual incentive equal to 120% of base salary (maximum 200% of target), and a 2026 long‑term incentive target of $2,500,000 under the 2022 Omnibus Equity Compensation Plan. If terminated by the company other than for cause, he is eligible for a lump sum equal to two times base salary, specified bonus components, continued vesting treatment on equity awards, and up to 18 months of COBRA and welfare benefits.
The Board also appointed Frances F. Townsend as Chair effective January 1, 2026. A news release covering these changes was furnished under Item 7.01.